|4Dec 17, 5:19 PM ET

Bouillonnec Herve 4

4 · INTERPARFUMS INC · Filed Dec 17, 2025

Insider Transaction Report

Form 4
Period: 2025-12-15
Bouillonnec Herve
DirectorGlobalChief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-15$73.09/sh+1,500$109,6351,500 total
  • Exercise/Conversion

    Option-right to buy

    2025-12-153000 total
    Exercise: $73.09From: 2020-12-31Exp: 2025-12-30Common Stock (300 underlying)
Holdings
  • Common Stock

    0
  • Option-right to buy

    Exercise: $97.84From: 2023-12-31Exp: 2028-12-30Common Stock (1,000 underlying)
    1,000
  • Option-right to buy

    Exercise: $147.71From: 2024-12-29Exp: 2029-12-28Common Stock (800 underlying)
    800

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT